Today, Medicenna Therapeutics Corp opened at $1.84 and closed at $1.73. Intraday prices ranged from a low of $1.72 to a high of $1.89.

Share prices dipped -5.98 percent from the previous day's close of $1.84.

Today across North America, the TSX Composite closed -0.45% at 21642.87, the S&P 500 closed -0.21% at 5051.41, the Dow Jones Industrial Average closed 0.17% at 37798.97 and the Nasdaq Composite closed -0.12% at 15865.25.

Medicenna Therapeutics Corp traded under MDNA on the Toronto Stock Exchange (TSX).

Trading volume was 158,701 on 314 total trades, with an average volume of 194,817 over the last 5 days.

The TSX market on the whole today saw 2,131 price advancers against 3,083 declines and 114 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.10 (March 28,2024) and low as $0.22 (November 01,2023). Moreover, in the last 12 months, Medicenna Therapeutics Corp's shares have risen 116.25 percent, while they have risen 311.90% year-to-date.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $128.13 million on a float of 69,637 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Medicenna Therapeutics Corp's average recommendation is "Strong Buy" based on 2.00 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..